Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
Date:8/9/2012

SAN FRANCISCO, Aug. 9, 2012 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the second quarter ended June 30, 2012.

Cash, cash equivalents, and investments at June 30, 2012 were $477.1 million as compared to $498.8 million at March 31, 2012.
This cash balance does not include the proceeds from the $125.0 million issuance of Senior Secured Notes that closed on July 11, 2012.

"I continue to be extremely pleased with Nektar's performance," said Howard W. Robin, President and Chief Executive Officer of Nektar. "The Phase 3 program for naloxegol is on track and AstraZeneca and Nektar plan to announce high-level results from the pivotal efficacy studies in the fourth quarter of 2012. NKTR-181 received Fast-Track designation from the FDA reflecting the important medical need addressed by this new opioid molecule. In July, we further strengthened our financial position with the $125 million private placement of Senior Secured Notes with no equity dilution to our shareholders."

Revenue for the second quarter of 2012 was $23.7 million, an increase as compared to $17.3 million in the second quarter of 2011. Year-to-date revenue for 2012 was $41.6 million, an increase as compared to $28.6 million for the first half of 2011.  The increases in 2012 compared to 2011 are due to a combination of increased product sales, royalties, and other collaboration revenues.  

Total operating costs and expenses in the second quarter of 2012 were $50.7 million as compared to $51.6 million in the second quarter of 2011.
Total operating costs and expenses for the first half of 2012 were $106.6 million as compared to $96.8 million in the first half of 2011.  Total operating expenses in the first half of 2012 increased as a result of higher cost of goods related to increased product sales as well as increase
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
3. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
4. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
5. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
6. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
7. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
8. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
9. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... YORK , Sept. 22, 2014 ... exclusive, global license agreement with Plasma Technologies LLC ... proprietary plasma fractionation process. Concurrently, the Company announced ... to strategically refocus and rebrand the company as ... a national listing for its common shares. ...
(Date:9/22/2014)... , Sept. 22, 2014 Research ... "Global and Chinese Diclofenac Industry Report 2014" report ... Chinese Diclofenac Industry Report 2014 is a professional and ... diclofenac industry with a focus on the Chinese situation. ... the industry including definitions, classifications, applications and industry chain ...
(Date:9/20/2014)... OTTAWA , Sept. 20, 2014 /CNW/ - The issue: ... voluntarily recalling all lots of its Mylan-Nitro Spray 0.4 mg/metered ... is part of the pump component. A ... delivery of nitroglycerin to the patient. This defect may lead ... fact they are unable to access it. Not receiving nitroglycerin ...
Breaking Medicine Technology:Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 2Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 5Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 6Global and Chinese Diclofenac Industry Report 2014 2Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2
... Consumers who have Medicare can now access updated ... conditions and coverage options, thanks to the re-release ...   http://photos.prnewswire.com/prnh/20100615/NCOALOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20100615/NCOALOGO ... Council on Aging (NCOA), the site offers users ...
... Roche Molecular Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today ... the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for ... a fully automated solution for the quantitative detection of hepatitis ... patients on HBV antiviral therapy.   "This new ...
Cached Medicine Technology:MyMedicareMatters Website Expands Coverage of Critical Medicare Information 2MyMedicareMatters Website Expands Coverage of Critical Medicare Information 3Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test 2Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test 3
(Date:9/22/2014)... Recent two-generation approaches to reducing poverty that help ... from researchers, advocates, and foundations. By combining education ... move to jobs that offer a path out ... for children, these programs aim to improve the ... a new report from the National Center for ...
(Date:9/22/2014)... The Workgroup for Electronic ... authority on the use of health IT to ... from its recent industry survey on the use ... electronic transactions adopted under the Health Insurance Portability ... from August 20 to September 5, which included ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. ... wonders: What can I do to help ensure a healthy ... prescribed may play a role in reducing the risk of ... researchers found that mothers of children with autism were significantly ... pregnancy than those whose children seem to be developing normally. ...
(Date:9/22/2014)... Severe weather can occur with little warning, so it’s ... of National Preparedness Month, Amica Insurance is offering the ... unexpected:, , Build an emergency supply kit. It ... gallon of water per person per day for at least 72 ... includes pets so your family knows what to do and where ...
(Date:9/22/2014)... 22, 2014 The struggles that lie ... (LEP) patients has been well-documented—reportedly, language barriers between doctors ... to the emergency room and an increased likelihood for ... At Sanford Health, the largest medical facility in the ... LEP population necessitated the need for Video Remote ...
Breaking Medicine News(10 mins):Health News:A two-generation lens: Current state policies fail to support families with young children 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 2Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 3Health News:Amica Shares Tips for National Preparedness Month 2Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 2Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 3Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 4
... the computers are sought in order to develop a vaccine ... have the ability to perform difficult task and can work ... good at handling long and complex problems with ease. In ... a cure against bird flu. Mostly computers that can crunches ...
... associated with spinal tumors has been developed by a ... vertebrae is a common feature in 5 to 10 ... ,Wade Wong, D.O.F.A.C.R, UCSD professor of radiology, ... spinal tumors from 28 patients before repairing the spine ...
... although prostate cancer was extremely dangerous, men over 75, ... radical prostatectomy or radiation does help to ... elders is often affected because of resulting urinary incontinence ... M. Hoffman, an associate professor of medicine at the ...
... is believed to play a key role in the development ... that the revelation could be of immensely helpful for the ... an enzyme called telomerase is believed to contribute to the ... tumors. A lack of detailed information regarding its structure had ...
... laureate hopes to manufacture plentiful anti-flu drugs at a cheaper ... work out the method while relaxing at home on a ... and given it to World Health Organization to prevent any ... for the production cycle is a compound extracted from the ...
... officials of the NHS Grampian said that people were offered ... NHS health board said so defending their decision to house ... ,A spokeswoman for NHS Grampian said a doctor always ... for a patient to stay outwith the city's Royal Infirmary. ...
Cached Medicine News:Health News:Novel Technique To Revolutionize Treatment Of Spinal Tumors 2
... 3000 Plus Sectioning System provides a versatile ... or plant tissues. The 3000 employs ... without freezing or embedding. The creation ... destruction of enzyme activities, and other deleterious ...
... standard with a square vice mounting ... utilized for mounting specimens and placing ... The blocks are annodized black for ... reused. They are shipped three ...
Injector blades come ten to an injector and allow for the easy replacement of Vibratome cutting blades....
... includes everything from the care package ... Spare Fluorescent Bulb, additional Vibratome Feather ... and a Specimen Tray. ... 1/2" speciment mounts, replacement rotating mounts, ...
Medicine Products: